Clinical Trial: An exploratory study of adebelimab combined with chemotherapy with or without cetuximab as neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma (China)

Posted On: 2026-09-30

China, Sept. 30 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An exploratory study of adebelimab combined with chemotherapy with or without cetuximab as neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133554

Registration Time: 2026/09/29

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Dalian Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344056

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: An exploratory study of adebelimab combined with chemotherapy with or without cetuximab as neoadjuvant therapy for locally advanced head and neck squamous cell carcinoma (China)